Quantbot Technologies’s Dyne Therapeutics DYN Stock Holding History

Quantbot Technologies’s Portfolio DYN Stock Details DYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.9K	Buy	+1,098	New	+$18.9K	﹤0.01%	1486
2025 Q4	–	Sell	-17,513	Closed	-$222K	–	1820
2025 Q3	$222K	Buy	+17,513	New	+$200K	0.01%	1261
2024 Q4	–	Sell	-959	Closed	-$34.4K	–	1566
2024 Q3	$34.4K	Buy	+959	New	+$38.2K	﹤0.01%	1319
2023 Q1	–	Sell	-400	Closed	-$4.64K	–	1676
2022 Q4	$4.64K	Buy	+400	New	+$4.63K	﹤0.01%	1559
2022 Q3	–	Sell	-2,100	Closed	-$14K	–	1703
2022 Q2	$14K	Sell	2,100 -800	-28%	-$5.51K	﹤0.01%	1493
2022 Q1	$27K	Sell	2,900 -100	-3%	-$851	﹤0.01%	1317
2021 Q4	$35K	Sell	3,000 -1,400	-32%	-$19.7K	﹤0.01%	1113
2021 Q3	$71K	Buy	+4,400	New	+$78K	0.01%	1045

Other funds holding DYN

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Quantbot Technologies's DYN Position: Q1 2026 in Review

Quantbot Technologies opened a new position in Dyne Therapeutics (DYN) in Q1 2026: 1,098 shares worth $19.9K. The stake represents ﹤0.01% of the portfolio and ranks #1486 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in DYN as recently as Q3 2025.

Quantbot Technologies first reported a position in DYN in Q3 2021 and has held it in 8 quarters since. The position peaked at $222K in Q3 2025. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

Quantbot Technologies held 1,098 shares of Dyne Therapeutics worth $19.9K as of Q1 2026.
Dyne Therapeutics was a new Quantbot Technologies position in Q1 2026.
Dyne Therapeutics made up ﹤0.01% of Quantbot Technologies's portfolio in Q1 2026, its #1486 holding.
Quantbot Technologies first reported a position in Dyne Therapeutics in Q3 2021 and has held it in 8 quarters since.
Quantbot Technologies's Dyne Therapeutics position peaked at $222K in Q3 2025.
227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.